Title: Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature.
Authors: Winkelhorst D, Kamphuis MM, de Kloet LC, Zwaginga JJ, Oepkes D, Lopriore E. Author information
Title: T cell responses to human platelet antigen–1a involve a unique form of indirect allorecognition
Authors: Maria Therese Ahlen, Anne Husebekk, Ida Løken Killie, Bjørn Skogen and Tor Brynjar Stuge
Title: Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia
Lakkaraja M, Jin JC, Manotas KC, Vinograd CA, Ferd P, Gabor J, Wissert M, Berkowitz RL, McFarland JG, Bussel JB.
Title: Fetal genome profiling at 5 weeks of gestation after noninvasive isolation of trophoblast cells from the endocervical canal
Authors: Chandni V. Jain,1,2* Leena Kadam,1,2* Marie van Dijk,3 Hamid-Reza Kohan-Ghadr,1 Brian A. Kilburn,1 Craig Hartman,4 Vicki Mazzorana,4 Allerdien Visser,3 Michael Hertz,1 Alan D. Bolnick,1 Rani Fritz,1 D. Randall Armant,1,5,6 Sascha Drewlo1†
Title: Old tools revisited give hope – new treatment option for families with a history of severe FNAIT complications.
Authors: Heidi Tiller 1,2, Peter Fedorcsak 3 and Bjørn R. Skogen 2,4
1 Department of Obstetrics and Gynecology, University Hospital North Norway, Tromsø, Norway,
2 Immunology Research Group, Department of Medical Biology, The Arctic University of Norway, Tromsø, Norway.
3 Section for Reproductive Medicine, Department of Gynecology, Oslo University Hospital, Oslo, Norway, 4 Department of Laboratory Medicine,University Hospital North Norway, Tromsø, Norway
Title: Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry
Gemma L. Crighton1,2,3, Ri Scarborough1, Zoe K. McQuilten1,4, Louise E. Phillips1, Helen F. Savoia3,5, Bronwyn Williams6,7, Rhonda Holdsworth2, Amanda Henry8,9,
Erica M. Wood1,10 and Stephen A. Cole5; On behalf of the Australian NAIT registry steering committee
1 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia, 2 Australian Red Cross Blood Service, Melbourne, Australia, 3 The Royal Children’s Hospital, Melbourne, Australia, 4 Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), Melbourne, Australia, 5 The Royal Women’s Hospital, Melbourne, Australia, 6 Royal Brisbane and Women’s Hospital, Brisbane, Australia, 7 Lady Cilento Children’s Hospital, Brisbane, Australia, 8School of Women’s and Children’s Health, University of New South Wales, Australia,
9 St George Hospital, Sydney, Australia, and 10Monash Medical Centre, Melbourne, Australia
Title: Fetal and neonatal alloimmune thrombocytopenia
Authors: Darko Zdravica, b, c, d, Issaka Yougbareb, c, d, Brian Vadasza, b, c, Conglei Lia, b, c, Alexandra H. Marshallb, c, Pingguo Chenb, c, d, Jens Kjeldsen-Kraghb, e, Heyu Nia, b, c, d, e, f, g, ,
a Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
b Toronto Platelet Immunobiology Group, Toronto, ON, Canada
c Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St Michael’s Hospital, Toronto, ON, Canada
d Canadian Blood Services, Toronto, ON, Canada
e Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories Region Skåne, Lund, Sweden
f Department of Medicine, University of Toronto, Toronto, ON, Canada
g Department of Physiology, University of Toronto, Toronto, ON, Canada
Title: Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention
Authors: Ewa Brojer 1. Anne Husebekk 2. Marzena Debska 3. Malgorzata Uhrynowska 1. Katarzyna Guz 1. 1. 3. 1.
1. Department of Immunohematology and Immunology of Transfusion Medicine Institute of Hematology and Transfusion Medicine Warsaw Poland.
2. Institute of Medical BiologyUiT The Arctic University of Norway Tromsø Norway.
3. 2nd Department of Obstetrics and GynecologyMedical Centre of Postgraduate Education, Warsaw Poland.
VIDEO: Risk Factors for Fetal and Neonatal Alloimmune Thrombocytopenia
Transfusion News, January, 2016.
Dr. Bussel, who wrote an Editorial on the subject, discusses the morbidity and mortality associated with NAIT.
Title: What do we know about intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia?
Author: James B. Bussel MD Weill-Cornell Medical College, New York, NY
Title: Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage
Authors: Florent Delbos1, Gérald Bertrand3 Laure Croisille1, Hélène Ansart-Pirenne1, Philippe Bierling1,2 and Cécile Kaplan3
Author Information: 1 Laboratoire HLA/ILP, Etablissement Français du Sang, Créteil. 2 IMRB, University Paris Est Créteil (UPEC), INSERM U955, Créteil, France. 3 Pla.elet Immunology, Institut National de la Transfusion Sanguine, Paris, France.
Transfusion related acute lung injury (TRALI)
Author: Dr Tom Latham